DDAB Liposomes (CAT#: LDLY-0123-LY182)

Description
Cationic liposomes are used for the delivery of genetic materials such as various types of DNA and RNA. In order to capture more plasmid efficiently, the negative charge of pDNA is neutralized with positive charge of cationic lipids due to electrostatic interaction and deliver them into cells. So they are researched for use as delivery vectors in gene therapy.
Applications
Cancer research; Target delivery
Format
Liquid
Hydration Solution
Deionized RNAse-free Water
External Solution
Deionized RNAse-free Water
Storage
2°C - 8°C in dark (do not freeze)
Size
100 nm
Shelf Life
6 months
Quantity
5mL (available in lyophilized powder)
Download
DataSheet MSDS
FAQs Published Data Customer Reviews Related Sections
  1. What are the potential research applications of DDAB liposomes?

    DDAB liposomes find applications in various research areas including drug delivery, gene therapy, vaccine development, and nanomedicine. Researchers utilize these versatile lipid-based carriers to deliver therapeutic agents or genetic materials with improved specificity and efficacy, contributing to advancements in biomedical science.

  2. What concentration of DDAB liposomes is suitable for my experiments?

    The optimal concentration of DDAB liposomes depends on the specific experimental setup and the intended application. Researchers typically conduct dose-response studies to determine the appropriate concentration range that achieves desired effects while minimizing potential cytotoxicity.

  3. How can I characterize the size and stability of DDAB liposomes?

    Several techniques can be employed to characterize DDAB liposomes, including dynamic light scattering (DLS) for size measurement and zeta potential analysis for surface charge determination. Additionally, stability studies involving storage conditions and serum stability assays can provide insights into liposomal behavior over time.

  4. What methods can be used for loading drugs or nucleic acids into DDAB liposomes?

    Various methods exist for loading therapeutic cargoes into DDAB liposomes, including passive encapsulation during liposome formation, active loading techniques such as pH gradient or transmembrane ammonium sulfate gradients, and post-insertion methods where preformed liposomes are incubated with the payload.

  5. How do I optimize the formulation of DDAB liposomes for my specific application?

    Optimization of DDAB liposome formulation involves adjusting parameters such as lipid composition, drug-to-lipid ratio, and preparation methods to achieve desired characteristics such as size, stability, and drug release kinetics. Systematic screening and characterization are essential for identifying the optimal formulation.

DDAB Liposomes-fig1


Cellular uptake of lipoplexes in MCF-7 and HeLa cells

The research provided focuses on the development and application of cationic liposomes formed from mixtures of lecithin and dihexadecyldimethylammonium bromide (DDAB) for the purpose of efficient gene delivery. This study underscores the effectiveness of spontaneously formed cationic vesicles in transfecting plasmid DNA (pDNA) and siRNA into cells, showcasing a novel method for gene therapy. The experimental results reveal that by adjusting the DDAB to phospholipid ratio within these vesicles, their average size can be controlled within the range of 150-300 nm, with a ζ potential of +40 mV, indicative of their cationic nature. The ability of these vesicles to bind and form complexes with pDNA, referred to as lipoplexes, is thoroughly demonstrated through a variety of assays, including ζ potential measurement, isothermal titration calorimetry, and DNase I digestion assay, among others. A particularly significant finding is the binding enthalpy between pDNA and cationic liposome, calculated as -5.7 (±0.8) kJ/mol, emphasizing the favorable energetics of this interaction. Cellular uptake studies further confirm the vesicles' capability to efficiently deliver genetic material into MCF-7 and HeLa cells, with fluorescence microscopy showcasing successful transfection. Additionally, the study elaborates on the potential of these cationic vesicles in delivering siRNA for gene silencing, marking a significant step forward in the utilization of DDAB liposomes for gene delivery applications. This research holds profound implications for the field of gene therapy, presenting a scalable and effective method for the delivery of therapeutic genes and RNA into cells.

Shelar, S. B., Dey, A., et al. Spontaneous Formation of cationic vesicles in aqueous DDAB-Lecithin mixtures for efficient plasmid DNA complexation and gene transfection. ACS Applied Bio Materials. 2021, 4(8): 6005-6015.

  • Enhanced Drug Delivery Efficiency
    The DDAB liposomes from Creative Biolabs outshine competitors with superior drug encapsulation and release properties. Their formulation significantly boosts drug delivery, aiding our research in targeted therapy development.
  • Exceptional Stability and Compatibility
    Creative Biolabs' DDAB liposomes exhibit remarkable stability and compatibility, offering a reliable platform for our drug development studies. Their consistency and efficacy surpass other options in the market.
  • Optimal Particle Size and Homogeneity
    Using Creative Biolabs' DDAB liposomes has been a game-changer in our research. The precise control over particle size and homogeneity enhances drug loading efficiency, providing unparalleled results in our experiments.
  • Outstanding Cellular Uptake
    We are impressed by the exceptional cellular uptake achieved with Creative Biolabs' DDAB liposomes. Their advanced formulation facilitates efficient intracellular delivery, surpassing competitors in our drug delivery studies.
  • Superior Research Support
    Creative Biolabs' DDAB liposomes have significantly advanced our drug development efforts. Their dedicated support team ensures seamless integration into our research protocols, making them our preferred choice for lipid-based drug delivery systems.

Click the button below to contact us or submit your feedback about this product.

For Research Use Only. Not For Clinical Use

Online Inquiry